Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Besançon 17 Créteil 11 Paris 11 Lille 11 Lyon 10
Narrow the registerReset
Recruitment status
Phase
Site location
Besançon17 Créteil11 Paris11 Lille11 Lyon10
All 47 locations
Target enrolment
to

Trials with a site in Paris

11 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
162
Amiens, Besançon, Caen, La Roche-sur-Yon, Lille, Lyon, Paris, Pessac
2025-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
60
Avignon, Besançon, Levallois-Perret, Lyon, Paris, Pessac, Poitiers, Toulouse
2025-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
206
Besançon, La Tronche, Lille, Paris, Poitiers, Reims, Saint-Cloud, Saint-Etienne
2025-07
Recruiting
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
NCT05787197Metastatic Colorectal Cancer, Circulating Tumor DNA
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
232
Besançon, Bordeaux, Lille, Lyon, Paris, Pessac, Poitiers, Rouen
2024-01-09
Recruiting
Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
NCT05850130Colorectal Cancer, Liver Cancer, Gastric Cancer, Pancreas Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
182
Amiens, Caen, Créteil, Grenoble, Lille, Nîmes, Paris, Saint-Cloud
2023-11-22
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
30
Besançon, Bordeaux, Lille, Limoges, Lyon, Montpellier, Nice, Paris
2022-05-05
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
78
Amiens, Besançon, Clichy, Dijon, Lyon, Marseille, Paris, Pessac
2021-01-05
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
32
Besançon, Créteil, Levallois-Perret, Lille, Lyon, Montpellier, Nantes, Paris
2019-10-23
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
57
Avignon, Besançon, Créteil, Levallois-Perret, Lyon, Nantes, Paris, Poitiers
2017-12-04
Active, closed
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483Pancreas, Management Supportive Care Program
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
110
Avignon, Clichy, Créteil, Levallois-Perret, Lyon, Mont-de-Marsan, Paris, Thonon-les-Bains
2016-12-19
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
4,050
Besançon, Clichy, Créteil, Lille, Lyon, Nancy, Paris, Poitiers
2003-01-01
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 1 November 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

5 of the 11 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 3 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 11 studies
PhaseStudiesRecruitingShare
Phase 27263.6%
Not applicable2118.2%
Observational2218.2%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
GERCOR - Multidisciplinary Oncology Cooperative Group115
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.